Company intelligence / Profile preview

emol

Toshima-ku, Tokyo, Japanemol.com ↗

Ownership: Private
Development stage: Commercial

Overview

emol offers AI-powered, chat-based cognitive behavioral therapy applications designed to support individuals with mental health needs. The company has been recognized as an outperformer among leading mental health chatbot providers and serves both consumers and healthcare professionals seeking scalable, evidence-based virtual care solutions. It has raised $2.66M in funding as of its last Series A round five months ago.

Therapeutic areas: Psychiatry
Modalities: Digital therapeutic applicationCognitive behavioral therapy (CBT) app
Industry: Digital Health Medical Devices

Partnerships

Collaborates with clinical providers and research organizations for data aggregation and analytics services related to patient care improvement in biosciences/oncology sectors

Beyond the preview

Go deeper on emol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on emol.

Explore the full profile